PD-L1 upregulation by lytic induction of Epstein-Barr Virus - ScienceDirect

Progress in Natural Compounds/siRNA Co-delivery Employing Nanovehicles for Cancer Therapy

RSV Downregulates IL-21/IL-21R On TFH Cells VIA PD-L1 Induction in APCS Impairing Protective Humoral Responses

The lytic phase of Epstein–Barr virus plays an important role in tumorigenesis

IJMS, Free Full-Text

Cancers, Free Full-Text

The role of Epstein–Barr virus-encoded latent membrane proteins in host immune escape

PDF) The oncogenic gamma herpesviruses Epstein-Barr virus (EBV) and Kaposi's sarcoma-associated herpesvirus (KSHV) hijack retinoic acid-inducible gene I (RIG-I) facilitating both viral and tumour immune evasion

Cyclin-dependent Kinases as Emerging Targets for Developing Novel Antiviral Therapeutics: Trends in Microbiology

PD-L1 upregulation by lytic induction of Epstein-Barr Virus - ScienceDirect

CAR-T Cells Targeting Epstein-Barr Virus gp350 Validated in a Humanized Mouse Model of EBV Infection and Lymphoproliferative Disease: Molecular Therapy - Oncolytics

Polyploid giant cancer cells, EZH2 and Myc upregulation in mammary epithelial cells infected with high-risk human cytomegalovirus - eBioMedicine